126 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Esperion Competitors or Alternatives

Esperion's top competitors include Regeneron, Daiichi Sankyo and Amryt Pharma.

Unlock 13 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Esperion's company profile

Sheldon Koenig

President & CEO

83/100
200
$845.4M
$303.8M
  • $845.4M
    $303.8M
  • 200
    $845.4M
  • $303.8M
  • 83/100
  • 200
  • $845.4M
  • $303.8M
View ProfileView
1
Esperion's Competitor - Regeneron logo

Leonard S. Schleifer

President & CEO

80/100
11,900
$2.1B
$14.2B
  • $2.1B
    $14.2B
  • 11,900
    $2.1B
  • $14.2B
  • 80/100
  • 11,900
  • $2.1B
  • $14.2B
View ProfileView
2
Esperion's Competitor - Daiichi Sankyo logo

Hiroyuki Okuzawa

President & CEO

82/100
19,765
- -
$13.4B
  • - -
    $13.4B
  • 19,765
    - -
  • $13.4B
  • 82/100
  • 19,765
  • - -
  • $13.4B
View ProfileView
3
Esperion's Competitor - Amryt Pharma logo

Joseph Wiley

Co-Founder & CEO

90/100
250 - 500
$155.8M
$100M - 500M
  • $155.8M
    $100M - 500M
  • 250 - 500
    $155.8M
  • $100M - 500M
  • 90/100
  • 250 - 500
  • $155.8M
  • $100M - 500M
View ProfileView
4
Esperion's Competitor - Sanofi logo

Paul Hudson

CEO

63/100
82,878
$4.7B
$42.4B
  • $4.7B
    $42.4B
  • 82,878
    $4.7B
  • $42.4B
  • 63/100
  • 82,878
  • $4.7B
  • $42.4B
View ProfileView
5
Esperion's Competitor - Amgen logo

Robert A. Bradway

Chairman & CEO

63/100
25,200
$4.1B
$36B
  • $4.1B
    $36B
  • 25,200
    $4.1B
  • $36B
  • 63/100
  • 25,200
  • $4.1B
  • $36B
View ProfileView
Esperion's top 16 competitors are Regeneron, Daiichi Sankyo, Amryt Pharma, Amarin, Sanofi, Amgen, AbbVie, Trygg Pharma As, Ra Pharma, Acasti Pharma, Lilly, Apellis, Merck, XOMA Royalty, Cambrex and Cardialen. Together they have raised over 33.5B between their estimated 301.5K employees. Esperion has 200 employees and is ranked 12th among it's top 10 competitors. The top 10 competitors average 18,856.

Esperion VS Regeneron

Regeneron is perceived as one of Esperion's biggest rivals. Regeneron was founded in 1988, and its headquarters is in Tarrytown, New York. Like Esperion, Regeneron also works within the Pharmaceuticals & Biotechnology field. Regeneron has 11,700 more employees than Esperion.

Esperion VS Daiichi Sankyo

Daiichi Sankyo is one of Esperion's top rivals. Daiichi Sankyo is a Public company that was founded in 2005 in Chuo-ku, Tōkyō Prefecture. Like Esperion, Daiichi Sankyo also competes in the Pharmaceuticals sector. Compared to Esperion, Daiichi Sankyo has 19,565 more employees.

Esperion VS Amryt Pharma

Amryt Pharma is Esperion's #3 rival. Amryt Pharma is a Private company that was founded in London, England in 2015. Like Esperion, Amryt Pharma also operates in the Pharmaceuticals sector. Amryt Pharma has 89 more employees vs. Esperion.

Looking for similar companies to Esperion?

Similar Companies

Companies in Ann Arbor with revenue in $100-500M range

See 18 companies 
Pharmaceuticals companies in Ann Arbor

See 22 companies 
Companies in Ann Arbor with employees in 250-500 range

See 60 companies 
Pharmaceuticals & Biotechnology companies in Ann Arbor

See 55 companies 
Pharmaceuticals companies in Detroit Metropolitan Area

See 93 companies 
Pharmaceuticals companies in Michigan

See 161 companies 
Pharmaceuticals & Biotechnology companies in Detroit Metropolitan Area

See 169 companies 
Companies in Detroit Metropolitan Area with revenue in $100-500M range

See 211 companies 
Pharmaceuticals & Biotechnology companies in Michigan

See 269 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Esperion and Esperion's Competitors

January 13, 2026Zacks
SNY wins EU approval for Teizeild, the first disease-modifying drug to delay stage 3 type 1 diabetes in adults and children aged eight and older....
January 13, 2026FiercePharma
AbbVie has announced a deal with the White House to lower the prices of certain medicines on Medicaid. At the same time, the Chicago-based company pled...
January 12, 2026Nasdaq
(RTTNews) - Esperion Therapeutics Inc. (ESPR) has reported strong preliminary financial results for the full-year 2025....
January 13, 2026Seeking Alpha
January 13, 2026PR Newswire
Ro's and Amgen's research will focus on barriers to care and improving access to treatment NEW YORK, Jan. 13, 2026 /PRNewswire/ -- Ro, the leading dire...
January 12, 2026Nasdaq
(RTTNews) - XOMA Royalty Corp. (XOMA), Monday announced that its Chief Financial Officer, Thomas Burns, has decided to step down from his position to p...
January 13, 2026Seeking Alpha
January 13, 2026DIGITIMES
Nvidia and Eli Lilly and Company have announced the formation of a joint AI co-innovation lab to apply artificial intelligence to drug discovery, devel...
January 12, 2026Seeking Alpha
January 12, 2026GlobeNewswire
Aclaris Initiates Phase 1b Proof-of-Concept Trial in Atopic Dermatitis (AD) with its Novel Bispecific Antibody ATI-052...

Frequently Asked Questions about Esperion

  1. Who are Esperion's top competitors?

    Esperion's top 3 competitors are Regeneron, Daiichi Sankyo, Amryt Pharma.

  2. Who is similar to Esperion?

    Regeneron is the most similar to Esperion. Daiichi Sankyo and Amryt Pharma are also similar to Esperion.

  1. Are Esperion and Regeneron competitors?

    Yes, Regeneron is one of Esperion’s top competitors.